Corpus Intelligence IC Memo — BAXTER REGIONAL MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — BAXTER REGIONAL MEDICAL CENTER
Investment Committee Memorandum | AR | 169 beds | Grade B | EBITDA uplift $20.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAXTER REGIONAL MEDICAL CENTER

CCN 040027 | BAXTER, AR | 169 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

BAXTER REGIONAL MEDICAL CENTER is a 169-bed suburban community hospital in BAXTER, AR with $282.2M in net patient revenue and a -2.8% operating margin. The hospital serves a payer mix of 34.4% Medicare, 7.2% Medicaid, and 58.5% commercial.

Thesis: Undervalued. Our ML models identify $20.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.8% to 4.6% (+736bps).

Net Revenue HCRIS$282.2M
Current EBITDA COMPUTED$-7.8M
Operating Margin COMPUTED-2.8%
Occupancy HCRIS60.5%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS35.4%
Distress Probability ML46.9%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
24
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -2.8% places it above the state median. Among 24 size-comparable peers (84-338 beds), the median margin is 0.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-338), prioritizing same-state peers. 24 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAXTER REGIONAL MEDICAL CENTER (Target)AR169$282.2M-2.8%
ARKANSAS CHILDRENS HOSPITALAR326$759.4M7.9%
MERCY HOSPITAL FORT SMITHAR256$447.1M13.8%
MERCY MEDICAL CENTERAR236$366.7M7.7%
NORTHWEST MEDICAL CENTERAR321$293.1M0.7%
BAPTIST HEALTH MEDICAL CENTER AR320$279.1M-13.1%
BAPTIST HEALTH MEDICAL CENTER-AR200$278.0M0.2%
ST. VINCENT HOT SPRINGSAR220$258.6M6.6%
WHITE COUNTY MEDICAL CENTERAR179$251.3M3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $20.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.9M+210bp18mo
Cost to Collect4.5%2.5%$5.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.4M+122bp9mo
Clean Claim Rate88.0%96.0%$181K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.9M
Cost to Collect
$5.6M
Denial Rate Reduction
$5.6M
A/R Days Reduction
$3.4M
Clean Claim Rate
$181K
Total EBITDA Uplift$20.8M
Current EBITDA$-7.8M
+ RCM Uplift+$20.8M
Pro Forma EBITDA$12.9M
Current Margin-2.8%
Pro Forma Margin4.6%
WC Released (1x)$10.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.1M$155.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.1M$167.6M0.00x-100.0%
Bull Case9.0x11.0x$-10.9M$232.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.9M$250.1M0.00x-100.0%
Bear Case11.0x10.0x$-13.3M$56.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.3M$57.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 24 hospitals with 84-338 beds
  • Same-state prioritization (n=25)
  • Comp margins: P25=-12.2% / P50=0.9% / P75=6.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.